Special Issue "Recent Advances in Immunocardiotoxicity"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 15 January 2024 | Viewed by 56
Special Issue Editor
Interests: cardio-oncology; heart failure
Special Issue Information
Dear Colleagues,
The cardiotoxicity of anti-cancer immunotherapies poses a major clinical challenge. To address the unanswered questions regarding immune-mediated myocarditis, a Special Issue is being published. The aim is to provide a comprehensive review of the research status, core problems, and scope of the issue.
This Special Issue covers the diagnostic approach, management, and monitoring of immune-mediated myocarditis. Experts in the field will present the latest research on the pathophysiological mechanisms of immune-mediated myocarditis, as well as treatment strategies and monitoring techniques.
Early diagnosis and treatment of immune-mediated myocarditis are crucial for better patient outcomes. By bringing together experts in the field, this Special Issue aims to develop effective strategies for the safe use of immunotherapies and improve patient outcomes.
Overall, this Special Issue mobilizes research efforts to provide a deeper understanding of immune-mediated myocarditis and contribute to improving patient outcomes.
Dr. Jennifer Cautela
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune checkpoint inhibitors
- immune-related adverse events
- myocarditis
- cardiotoxicity
- cancer
- diagnosis
- manage-ment
